Should You Buy AbbVie Stock Before Oct. 30?
Should You Buy AbbVie Stock Before Oct. 30? The Globe and Mail
Covered in this story
Analyst targets on AbbVie
- Bank of America: $262 → $289 by Sep 2027 · Buy via AOL.com
- Wells Fargo: $250 → $300 by Aug 2027 · Overweight via Investing.com
- Guggenheim: $244 → $288 by Aug 2027 · Buy via GuruFocus
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $ABBV yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on AbbVie →Also covered by 1 other outlet
Dalsna Finance is currently tracking 48 stories mentioning AbbVie, the earliest published 29 Apr 2026.
Summary aggregated from The Globe and Mail's public RSS feed. The full reporting belongs to The Globe and Mail — please read it on their site.